Ayala Pharmaceuticals Inc (ADXS)

[mypekeispooped]

AXAL, by itself, has been shown as a safe, effective therapy for cervical cancer. I imagine a triple combo with chemo, an anti-PD-1 agent and AXAL would have a synergistic effect. Merck seems to want throw Keytruda at every cancer and has already been approved for cervical in a second-line setting. It would take little money on Mercks part to license this application from Advaxis. They could possibly move from a PI (if promising) to a P3 fairly quickly. I am puzzled they have not, as yet, done so. IMHO